Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOPHOSPHAMIDE Cause Tuberculosis? 109 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Tuberculosis have been filed in association with CYCLOPHOSPHAMIDE (Cyclophosphamide). This represents 0.1% of all adverse event reports for CYCLOPHOSPHAMIDE.

109
Reports of Tuberculosis with CYCLOPHOSPHAMIDE
0.1%
of all CYCLOPHOSPHAMIDE reports
22
Deaths
33
Hospitalizations

How Dangerous Is Tuberculosis From CYCLOPHOSPHAMIDE?

Of the 109 reports, 22 (20.2%) resulted in death, 33 (30.3%) required hospitalization, and 15 (13.8%) were considered life-threatening.

Is Tuberculosis Listed in the Official Label?

Yes, Tuberculosis is listed as a known adverse reaction in the official FDA drug label for CYCLOPHOSPHAMIDE.

What Other Side Effects Does CYCLOPHOSPHAMIDE Cause?

Off label use (12,578) Febrile neutropenia (11,318) Drug ineffective (8,142) Neutropenia (7,352) Disease progression (7,100) Pyrexia (6,126) Product use in unapproved indication (5,750) Thrombocytopenia (4,669) Pneumonia (4,595) Nausea (4,561)

What Other Drugs Cause Tuberculosis?

INFLIXIMAB (1,247) ADALIMUMAB (1,047) METHOTREXATE (817) ETANERCEPT (632) GOLIMUMAB (413) CERTOLIZUMAB PEGOL (399) SECUKINUMAB (396) TOFACITINIB (301) PREDNISONE (283) ISONIAZID (261)

Which CYCLOPHOSPHAMIDE Alternatives Have Lower Tuberculosis Risk?

CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOSERINE CYCLOPHOSPHAMIDE vs CYCLOSPORINE

Related Pages

CYCLOPHOSPHAMIDE Full Profile All Tuberculosis Reports All Drugs Causing Tuberculosis CYCLOPHOSPHAMIDE Demographics